Form EFFECT ADARx Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 24, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- University of Phoenix Future of Skills Development report identifies workforce skills visibility gap as AI reshapes work
- BAYSTATE HEALTH ANNOUNCES PARTICIPATION IN NATIONAL CLINICAL TRIAL FOR ADVANCED BRAIN ANEURYSM TREATMENT
- Taiwan Expo USA 2026 Opens in Dallas, With an Expanded Showcase of Innovation and Culture
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
